Analysis of risk factors and prediction of prognosis in patients with primary liver cancer undergoing transarterial chemoembolization.

Front Oncol · 2026 · PMC13318757 · PMID 42388618

Europe PMC DOI

hedged sentence

0.0910

closest p · 1.8× alpha

0.0910

boldest claim

The sentences

did not reach statistical significanceP = 0.091so close (0.05 < p ≤ 0.1)

Patients with CR showed numerically longer post-landmark OS than those with PR, although the difference did not reach statistical significance (median OS, not reached [95% CI, 36.8–NR] vs 33.6 months [95% CI, 27.4–39.8]; 12-month OS, 95.2% vs 85.7%; 24-month OS, 81.4% vs 63.8%; log-rank P = 0.091).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.